Matinas BioPharma increases authorized common stock to 500M shares

Matinas BioPharma Holdings, Inc.

Authorized common shares doubled from 250M to 500M effective Aug 6, 2025.
Shareholder approval obtained at 2025 annual meeting on June 23, 2025.
Total authorized capital stock is now 510M shares (500M common + 10M preferred).
Certificate of Amendment filed with Delaware Secretary of State.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Matinas BioPharma Holdings, Inc.: Increased authorized shares of common stock from 250,000,000 to 500,000,000 (effective 2025-08-06).

Change: charter amendment
Effective: 2025-08-06

Exact text from the filing

On August 6, 2025, Matinas BioPharma Holdings, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock from 250,000,000 shares to 500,000,000 shares. The Certificate of Amendment was approved by the Company’s stockholders at the 2025 annual meeting on June 23, 2025 and became effective upon filing.

View on SEC.gov

11 governance changes filed in the last 30 days. Browse all governance changes →

Matinas BioPharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-022445

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.